Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Daniel L. Bourque"'
Autor:
Ana A. Weil, Crystal N. Ellis, Meti D. Debela, Taufiqur R. Bhuiyan, Rasheduzzaman Rashu, Daniel L. Bourque, Ashraful I. Khan, Fahima Chowdhury, Regina C. LaRocque, Richelle C. Charles, Edward T. Ryan, Stephen B. Calderwood, Firdausi Qadri, Jason B. Harris
Publikováno v:
mSphere, Vol 4, Iss 4 (2019)
ABSTRACT Vibrio cholerae infection provides long-lasting protective immunity, while oral, inactivated cholera vaccines (OCV) result in more-limited protection. To identify characteristics of the innate immune response that may distinguish natural V.
Externí odkaz:
https://doaj.org/article/4866f94033c54f77908b6cc981567724
Publikováno v:
Case Reports in Infectious Diseases, Vol 2016 (2016)
Leptotrichia species are normal constituents of the oral cavity and the genitourinary tract microbiota that are known to provoke disease in immunocompromised patients and rarely in immunocompetent individuals. Following the description of Leptotrichi
Externí odkaz:
https://doaj.org/article/17f965ff909b4b6fa52d51c0f25fc8c2
Autor:
Ludy R Carmola, Jacquelyn Turcinovic, Garrison Draper, David Webner, Margot Putukian, Holly Silvers-Granelli, Andrei Bombin, Bradley A Connor, Kristina Angelo, Phyllis Kozarsky, Michael Libman, Ralph Huits, Davidson H Hamer, Jessica K Fairley, John H Connor, Anne Piantadosi, Daniel L Bourque
Publikováno v:
Open Forum Infectious Diseases.
Background Professional soccer athletes are at risk of acquiring SARS-CoV-2 when traveling or through domestic community transmission. The U.S. Major League Soccer (MLS) league uses protocol-based SARS-CoV-2 testing for identification of individuals
Autor:
Arashdeep Rupal, Daniel L. Bourque, Scott J Morin, Chinmay Jani, Robert C. Colgrove, Harpreet Singh
Publikováno v:
American Journal of Therapeutics
Supplemental Digital Content is Available in the Text.
Publikováno v:
Journal of Travel Medicine. 29
Rationale for review Giardiasis is one of the most common human protozoal infections worldwide. First-line therapy of giardiasis includes nitroimidazole antibiotics. However, treatment failure with nitroimidazoles is increasingly reported, with up to
Autor:
Bradley A. Connor, Prativa Pandey, Martin P. Grobusch, Paul Kelly, Eli Schwartz, Frank P. Mockenhaupt, Eric Caumes, Silvia Odolini, Ralph Huits, Perry J.J. van Genderen, Patricia Schlagenhauf, Mogens Jensenius, Davidson H. Hamer, Anne E. McCarthy, Yukihiro Yoshimura, Daniel L. Bourque, Kristina M. Angelo, Karin Leder, Hilmir Asgeirsson, Katherine Plewes, Michael Libman, Stefan H.F. Hagmann, Daniel T. Leung, Adrián Sánchez-Montalvá, Gilles Eperon
Publikováno v:
Antimicrob Agents Chemother
Antimicrobial agents and chemotherapy, 64(11):e01084, e01084-20. American Society for Microbiology
Antimicrobial Agents & Chemotherapy, 64(11):e01084-20. American Society for Microbiology
Antimicrobial agents and chemotherapy, 64(11):e01084, e01084-20. American Society for Microbiology
Antimicrobial Agents & Chemotherapy, 64(11):e01084-20. American Society for Microbiology
Enteric fever, caused by Salmonella enterica serovar Typhi (S. Typhi) and S. enterica serovar Paratyphi (S. Paratyphi), is a common travel-related illness. Limited data are available on the antimicrobial resistance (AMR) patterns of these serovars am
Autor:
Karin Leder, Daniel L. Bourque
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Publikováno v:
Open Forum Infectious Diseases
Background Frequent observation of increasing fever and rising inflammatory markers late after onset of COVID-19 suggests Cytokine Release Syndrome (CRS, “Cytokine Storm”) may contribute to pathophysiology. Tocilizumab (TCZ), a monoclonal antibod
Autor:
Daniel L. Bourque, Lin H. Chen
Publikováno v:
Journal of Travel Medicine. 27
Autor:
Daniel L. Bourque, Ana A. Weil, Jason B. Harris, Stephen B. Calderwood, Taufiqur Rahman Bhuiyan, Ashraful Islam Khan, Fahima Chowdhury, Meti D. Debela, Edward T. Ryan, Richelle C. Charles, Crystal N. Ellis, Regina C. LaRocque, Firdausi Qadri, Rasheduzzaman Rashu
Publikováno v:
mSphere, Vol 4, Iss 4 (2019)
mSphere
mSphere
An episode of cholera provides better protection against reinfection than oral cholera vaccines, and the reasons for this are still under study. To better understand this, we compared the immune responses of human cells exposed to live Vibrio cholera